Dhib-Jalbut S - Search Results

1

Interferon-beta-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosis.

Graber J, Zhan M, Ford D, Kursch F, Francis G, Bever C, Panitch H, Calabresi PA, Dhib-Jalbut S. Graber J, et al. J Neuroimmunol. 2005 Apr;161(1-2):169-76. doi: 10.1016/j.jneuroim.2004.11.017. Epub 2005 Jan 25. J Neuroimmunol. 2005. PMID: 15748956 Clinical Trial.

2

Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration.

Khan OA, Xia Q, Bever CT Jr, Johnson KP, Panitch HS, Dhib-Jalbut SS. Khan OA, et al. Neurology. 1996 Jun;46(6):1639-43. doi: 10.1212/wnl.46.6.1639. Neurology. 1996. PMID: 8649563 Clinical Trial.

3

Cytokine changes during interferon-beta therapy in multiple sclerosis: correlations with interferon dose and MRI response.

Graber JJ, Ford D, Zhan M, Francis G, Panitch H, Dhib-Jalbut S. Graber JJ, et al. J Neuroimmunol. 2007 Apr;185(1-2):168-74. doi: 10.1016/j.jneuroim.2007.01.011. Epub 2007 Feb 27. J Neuroimmunol. 2007. PMID: 17328965 Free PMC article. Clinical Trial.

4

Stem cell based delivery of IFN-beta reduces relapses in experimental autoimmune encephalomyelitis.

Makar TK, Trisler D, Bever CT, Goolsby JE, Sura KT, Balasubramanian S, Sultana S, Patel N, Ford D, Singh IS, Gupta A, Valenzuela RM, Dhib-Jalbut S. Makar TK, et al. J Neuroimmunol. 2008 May 30;196(1-2):67-81. doi: 10.1016/j.jneuroim.2008.02.014. Epub 2008 May 8. J Neuroimmunol. 2008. PMID: 18471898

5

Effect of combined IFNbeta-1a and glatiramer acetate therapy on GA-specific T-cell responses in multiple sclerosis.

Dhib-Jalbut S, Chen M, Henschel K, Ford D, Costello K, Panitch H. Dhib-Jalbut S, et al. Mult Scler. 2002 Dec;8(6):485-91. doi: 10.1191/1352458502ms862oa. Mult Scler. 2002. PMID: 12474988 Clinical Trial.

6

Interferon beta-1b reduces interferon gamma-induced antigen-presenting capacity of human glial and B cells.

Jiang H, Milo R, Swoveland P, Johnson KP, Panitch H, Dhib-Jalbut S. Jiang H, et al. J Neuroimmunol. 1995 Aug;61(1):17-25. doi: 10.1016/0165-5728(95)00072-a. J Neuroimmunol. 1995. PMID: 7560008

7

Glatiramer acetate-reactive peripheral blood mononuclear cells respond to multiple myelin antigens with a Th2-biased phenotype.

Dhib-Jalbut S, Chen M, Said A, Zhan M, Johnson KP, Martin R. Dhib-Jalbut S, et al. J Neuroimmunol. 2003 Jul;140(1-2):163-71. doi: 10.1016/s0165-5728(03)00170-x. J Neuroimmunol. 2003. PMID: 12864985

8

Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle.

Makar TK, Bever CT, Singh IS, Royal W, Sahu SN, Sura TP, Sultana S, Sura KT, Patel N, Dhib-Jalbut S, Trisler D. Makar TK, et al. J Neuroimmunol. 2009 May 29;210(1-2):40-51. doi: 10.1016/j.jneuroim.2009.02.017. Epub 2009 Apr 10. J Neuroimmunol. 2009. PMID: 19361871

9

Hematopoietic progenitors express myelin basic protein and ensheath axons in Shiverer brain.

Goolsby J, Makar T, Dhib-Jalbut S, Bever CT Jr, Pessac B, Trisler D. Goolsby J, et al. J Neuroimmunol. 2013 Apr 15;257(1-2):13-20. doi: 10.1016/j.jneuroim.2013.01.004. Epub 2013 Feb 1. J Neuroimmunol. 2013. PMID: 23375677

10

Biomarkers of interferon Beta therapy in multiple sclerosis.

Graber JJ, Dhib-Jalbut S. Graber JJ, et al. J Interferon Cytokine Res. 2014 Aug;34(8):600-4. doi: 10.1089/jir.2013.0144. J Interferon Cytokine Res. 2014. PMID: 25084176 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters